Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements Vol. 6; no. 7; pp. 109 - 110
Main Authors: Wardlev, A, Anton-Torres, A, Pivot, X, Morales-Vasquez, F, Zetina, L, de Fatima Dias Gaui, M, Otero Reyes, D, Jassem, J, Button, P, Bell, R
Format: Journal Article
Language:English
Published: Elsevier Ltd 2008
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(08)70525-1